Location History:
- Oxford, GB (2014 - 2021)
- Wootton by Woodstock, GB (2024)
Company Filing History:
2 out of 3,539 
2 out of 7 
1 out of 22 
Years Active: 2014-2025
Title: **Leonard William Seymour: Innovator in Cancer Treatment**
Introduction
Leonard William Seymour is a notable inventor based in Wootton by Woodstock, GB. With two patents to his name, he has made significant contributions to the field of cancer treatment through innovative biomedical technologies.
Latest Patents
Seymour's most recent patents showcase his advancements in the utilization of modified adenoviruses for medical applications. One of his patents is focused on an "Adenovirus armed with bispecific T cell engager." This modified adenovirus, particularly Enadenotucirev (EnAd), features at least two bispecific T cell engagers. These engagers comprise binding domains that are specific for surface antigens on immune cells, specifically T-cells. The innovation includes a pharmaceutical formulation for treatment applications, particularly in cancer therapy. Additionally, his other patent describes an "Oncolytic group B adenovirus expressing a stroma-targeted bispecific T-cell engager." This also centers on Enadenotucirev, armed with a T-cell activator designed for targeted treatment of cancer.
Career Highlights
Leonard William Seymour works at Akamis Bio Limited, where he continues to push the boundaries of cancer research. His work stands out in the biopharmaceutical field, particularly in the development of virus-based therapies that harness the body's immune system to combat cancer cells.
Collaborations
Throughout his career, Seymour has collaborated with notable figures in the field, including his coworkers Brian Robert Champion and Alice Claire Noel Bromley. Together, they contribute to advancing research and the development of innovative therapeutic approaches.
Conclusion
Leonard William Seymour is an inventor whose contributions through his patents have the potential to significantly impact cancer treatment. His innovative work with modified adenoviruses represents a groundbreaking approach in the fight against cancer, showcasing the vital role of inventors in the realm of medical advancements.